RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ENTA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Enanta Pharmaceuticals stock price on Thursday
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 24.36% PDF

The Enanta Pharmaceuticals stock price gained 5.63% on the last trading day (Thursday, 28th Mar 2024), rising from $16.53 to $17.46. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.64% from a day low at $16.50 to a day high of $17.76. The price has risen in 7 of the last 10 days and is up by 25.97% over the past 2 weeks. Volume fell on the last day by -105 thousand shares and in total, 299 thousand shares were bought and sold for approximately $5.22 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $16.90, a level that may pose a second chance to hit a runner. According to fan-theory $19.67 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ENTA Signals & Forecast

The Enanta Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.37 and $14.21. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, March 18, 2024, and so far it has risen 29.24%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $16.53 and $15.95. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Enanta Pharmaceuticals finds support just below today's level at $16.53. If this is broken, then the next support from accumulated volume will be at $15.95 and $14.04.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.26 between high and low, or 7.64%. For the last week, the stock has had daily average volatility of 8.14%.

Our recommended stop-loss: $16.89 (-3.24%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (ENTA) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Enanta Pharmaceuticals to open at $17.24, and during the day (based on 14 day Average True Range), to move between $16.54 and $18.38, which gives a possible trading interval of +/-$0.92 (+/-5.29%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 10.59% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $16.53, some $0.93 (5.33%) from the current price of $17.46, our system finds the risk reward attractive.

Is Enanta Pharmaceuticals stock A Buy?

Enanta Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Enanta Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$17.24 ( 1.26%) $17.46

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ENTA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 18.50 5.96 %
R2 18.02 3.20 %
R1 17.72 1.50 %
Current price: 17.46
Support S1 16.76 -4.02 %
S2 16.46 -5.72 %
S3 15.98 -8.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 17.46
Support S1 16.53 -5.33%
S2 15.95 -8.65%
S3 14.04 -19.59%

FAQ

What is the symbol for Enanta Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Enanta Pharmaceuticals is ENTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Enanta Pharmaceuticals Stock?
Enanta Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy Enanta Pharmaceuticals Stock?
Enanta Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Enanta Pharmaceuticals Stock.

What's the current price of Enanta Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Enanta Pharmaceuticals (ENTA) share was $17.46.

What is the 52-week high and low for Enanta Pharmaceuticals Stock?
The 52-week high for Enanta Pharmaceuticals Stock is $41.45 and the 52-week low is $8.08.

What is the market capitalization of Enanta Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Enanta Pharmaceuticals is 349.709M.

When is the next earnings date for Enanta Pharmaceuticals?
The upcoming earnings date for Enanta Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT